ID.1
Item
histologically/cytologically confirmed adenocarcinoma of the breast, followed by adequate surgical resection and/or radiotherapy, and/or adjuvant chemotherapy, if indicated.
boolean
C0858252 (UMLS CUI [1,1])
C0679557 (UMLS CUI [1,2])
C0728940 (UMLS CUI [2])
C1522449 (UMLS CUI [3])
C0392920 (UMLS CUI [4])
ID.2
Item
stage t1-3 n0-2 mo, any tnm stage bc for whom adjuvant hormonal therapy is being considered.
boolean
C1515169 (UMLS CUI [1])
ID.3
Item
those patients not deemed to have had potentially curative primary surgical treatment or one of the following criteria:
boolean
C0038894 (UMLS CUI [1,1])
C1276305 (UMLS CUI [1,2])
ID.4
Item
inflammatory breast cancer
boolean
C0278601 (UMLS CUI [1])
ID.5
Item
histologically positive supraclavicular nodes
boolean
C0229730 (UMLS CUI [1,1])
C0019638 (UMLS CUI [1,2])
ID.6
Item
ulceration/infiltration of local skin metastasis
boolean
C0027627 (UMLS CUI [1,1])
C1123023 (UMLS CUI [1,2])
C0041582 (UMLS CUI [1,3])
C0332448 (UMLS CUI [1,4])
ID.7
Item
neoadjuvant chemotherapy
boolean
C0600558 (UMLS CUI [1,1])
C3665472 (UMLS CUI [1,2])
ID.8
Item
ductal carcinoma in situ (dcis) or lobular carcinoma in situ (lcis) without invasion
boolean
C0007124 (UMLS CUI [1])
C0279563 (UMLS CUI [2])
ID.9
Item
er and pr negative primary tumor or er/pr unknown status.
boolean
C2919271 (UMLS CUI [1])
C2919590 (UMLS CUI [2])